Interferon inducibility of STAT 1 activation and its prognostic significance in melanoma patients

Folia Biologica

Volumn 49, Issue 4, 2003, Pages 142-146

  Boudny V ^a   Kocak I ^a   Lauerova L ^a   Kovařík, Jan ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Interferons; Malignant melanoma; Signal transduction; Stat 1

Indexed keywords

ALPHA2B INTERFERON; CYTOPLASM PROTEIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTISERUM; RECOMBINANT ALPHA INTERFERON; RECOMBINANT GAMMA INTERFERON; SERINE; STAT1 PROTEIN; TYROSINE;

ADULT; ARTICLE; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CELL LYSATE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA BINDING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LYMPH NODE METASTASIS; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MELANOMA CELL; PROGNOSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

EID: 0042324670     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bowman, T., Garcia, R., Turkson, J., Jove, R. (2000) STATs in oncogenesis. Oncogene 19, 2474-2488.
2. Chawla-Sarkar, M., Leaman, D. W., Jacobs, B. S., Tuthill, R. J., Chatterjee-Kishore, M., Stark, G. R., Borden, E. C. (2002) Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1). J. Interferon Cytokine Res. 22, 603-613.
3. Decker, T., Kovarik, P. (2000) Serine phosphorylation of STATs. Oncogene 19, 2628-2637.
4. Durbin, J. E., Hackenmiller, R., Simon, M. C., Levy, D. E. (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450.
5. Frank, D. A. (1999) STAT signaling in the pathogenesis and treatment of cancer. Mol. Med. 5, 432-456.
6. Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro-Cacho, C. A., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S., Laudano, A., Gazit, A., Levitzki, A., Kraker, A., Jove, R. (2001) Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20, 2499-2513.
7. Klein, J. P., Moeschberger, M. L. (1997) Survival Analysis. Techniques for Censored and Truncated Data, pp. 502, Springer-Verlag, New York.
8. Kovarik, P., Mangold, M., Ramsauer, K., Heidari, H., Steinborn, R., Zotter, A., Levy, D. E., Muller, M., Decker, T. (2001) Specificity of signaling by STAT 1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J. 20, 91-100.
9. Levy, D. E. (1999) Physiological significance of STAT proteins: investigations through gene disruption in vivo. Cell. Mol. Life Sci. 55, 1559-1567.
10. Meraz, M. A., White, J. M., Sheehan, K. C., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., Carver-Moore, K., DuBois, R. N., Clark, R., Aguet, M., Schreiber, R. D. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442.
11. O'Shea, J. J., Gadina, M., Schreiber, R. D. (2002) Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109, Suppl. S121-S131.
12. Pansky, A., Hildebrand, P., Fasler-Kan, E., Baselgia, L., Ketterer, S., Beglinger, C., Heim, M. H. (2000) Defective JAK-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-alpha. Int. J. Cancer 85, 720-725.
13. Ramana, C. V., Gil, M. P., Han, Y., Ransohoff, R. M., Schreiber, R. D., Stark, G. R. (2001) Stat1-independent regulation of gene expression in response to IFN-gamma. Proc. Natl. Acad. Sci. USA 98, 6674-6679.
14. Ramana, C. V., Gil, M. P., Schreiber, R. D., Stark, G. R. (2002) Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol. 23, 96-101.
15. Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H., Schreiber, R. D. (1998) How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
16. Watson, C. J., Miller, W. R. (1995) Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br. J. Cancer 71, 840-844.
17. Wen, Z., Zhong, Z., Darnell, J. E. Jr. (1995) Maximal activation of transcription by STAT 1 and STAT 3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250.
18. Widschwendter, A., Tonko-Geymayer, S., Welte, T., Daxenbichler, G., Marth, C., Doppler, W. (2002) Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin. Cancer Res. 8, 3065-3074.
19. Wong, L. H., Krauer, K. G., Hatzinisiriou, I., Estcourt, M. J., Hersey, P., Tam, N. D., Edmondson, S., Devenish, R. J., Ralph, S. J. (1997) Interferon-resistant human melanoma cells are deficient in ISGF 3 components, STAT 1, STAT 2, and p48-ISGF 3gamma. J. Biol. Chem. 272, 28779-28785.
20. Zhou, Y., Wang, S., Gobl, A., Oberg, K. (2001) Interferon alpha induction of Stat1 and Stat2 and their prognostic significance in carcinoid tumors. Oncology 60, 330-338.